Patricia Lommel

2.8k total citations
15 papers, 2.0k citations indexed

About

Patricia Lommel is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Patricia Lommel has authored 15 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Microbiology and 2 papers in Infectious Diseases. Recurrent topics in Patricia Lommel's work include Bacterial Infections and Vaccines (14 papers), Pneumonia and Respiratory Infections (14 papers) and Respiratory viral infections research (6 papers). Patricia Lommel is often cited by papers focused on Bacterial Infections and Vaccines (14 papers), Pneumonia and Respiratory Infections (14 papers) and Respiratory viral infections research (6 papers). Patricia Lommel collaborates with scholars based in Belgium, Finland and Czechia. Patricia Lommel's co-authors include Lode Schuerman, Roman Prymula, Pavla Kriz, Igor Kohl, Viktor Chrobok, Elena Nováková, Pascal Peeters, Jan Poolman, Dorota Borys and Jean‐Paul Prieels and has published in prestigious journals such as The Lancet, The Lancet Infectious Diseases and Vaccine.

In The Last Decade

Patricia Lommel

15 papers receiving 2.0k citations

Peers

Patricia Lommel

EPIDE

MICRO

PRM

OTORH

Dorota Borys Belgium

Lolita Piglansky Israel

Rimma Melamed Israel

Ángela Gentile Argentina

Elina Lahti Finland

Taina Juvén Finland

Andrew Riordan United Kingdom

Juan José García‐García Spain

Tarja Heiskanen‐Kosma Finland

Jesús M Feris United States

Dorota Borys Belgium

Patricia Lommel

1.4k ×0.8

EPIDE

909 ×0.8

MICRO

180 ×0.8

PRM

68 ×0.4

OTORH

140 ×1.1

Citations per year, relative to Patricia Lommel Patricia Lommel (= 1×) peers Dorota Borys

Countries citing papers authored by Patricia Lommel

Since Specialization

Citations

This map shows the geographic impact of Patricia Lommel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Lommel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Lommel more than expected).

Fields of papers citing papers by Patricia Lommel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Lommel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Lommel. The network helps show where Patricia Lommel may publish in the future.

Co-authorship network of co-authors of Patricia Lommel

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Lommel. A scholar is included among the top collaborators of Patricia Lommel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Lommel. Patricia Lommel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kilpi, Terhi, Janne J. Jokinen, Taneli Puumalainen, et al.. (2018). Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial. Vaccine. 36(39). 5891–5901. 12 indexed citations

Sáez‐Llorens, Xavier, Arlene Calvo, María Mercedes Castrejón, et al.. (2017). Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children – A randomized controlled trial. Human Vaccines & Immunotherapeutics. 13(6). 1213–1228. 26 indexed citations

Vesikari, Timo, Aino Forstén, Tarja Kaijalainen, et al.. (2016). Effectiveness of the 10-Valent Pneumococcal NontypeableHaemophilus influenzaeProtein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland. Journal of the Pediatric Infectious Diseases Society. 5(3). 237–248. 70 indexed citations

Palmu, Arto A., Jukka Jokinen, Heta Nieminen, et al.. (2013). Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3–4 trial. The Lancet Infectious Diseases. 14(3). 205–212. 74 indexed citations

Palmu, Arto A., Jukka Jokinen, Dorota Borys, et al.. (2012). Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. The Lancet. 381(9862). 214–222. 173 indexed citations

Prymula, Roman, Miroslav Špliňo, Pavla Kriz, et al.. (2011). Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. Vaccine. 29(10). 1959–1967. 62 indexed citations

Vesikari, Timo, Aino Karvonen, Tiina Korhonen, et al.. (2010). Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months. The Pediatric Infectious Disease Journal. 29(6). e47–e56. 31 indexed citations

Silfverdal, Sven‐Arne, et al.. (2009). Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine. The Pediatric Infectious Disease Journal. 28(10). e276–e282. 48 indexed citations

Prymula, Roman, Claire‐Anne Siegrist, Roman Chlíbek, et al.. (2009). Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. The Lancet. 374(9698). 1339–1350. 249 indexed citations

10.

Bermal, Nancy, Leszek Szenborn, Edison Alberto, et al.. (2009). The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity. The Pediatric Infectious Disease Journal. 28(4). S89–S96. 75 indexed citations

11.

Chevallier, Bertrand, Timo Vesikari, Jerzy Brzostek, et al.. (2009). Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood Vaccines. The Pediatric Infectious Disease Journal. 28(4). S109–S118. 71 indexed citations

12.

Vesikari, Timo, Jacek Wysocki, Bertrand Chevallier, et al.. (2009). Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine. The Pediatric Infectious Disease Journal. 28(4). S66–S76. 213 indexed citations

13.

Prymula, Roman, Roman Chlíbek, Miroslav Špliňo, et al.. (2008). Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. Vaccine. 26(35). 4563–4570. 16 indexed citations

14.

Prymula, Roman, Pascal Peeters, Viktor Chrobok, et al.. (2006). Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. The Lancet. 367(9512). 740–748. 478 indexed citations

15.

Prymula, Roman, Pascal Peeters, Viktor Chrobok, et al.. (2006). Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non‐typable Haemophilus influenzae: a randomised double‐blind efficacy study. Clinical Otolaryngology. 31(5). 435–435. 448 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact